David Semela

9.3k total citations
85 papers, 3.1k citations indexed

About

David Semela is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, David Semela has authored 85 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hepatology, 43 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in David Semela's work include Liver Disease Diagnosis and Treatment (39 papers), Hepatitis C virus research (28 papers) and Liver Disease and Transplantation (18 papers). David Semela is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Hepatitis C virus research (28 papers) and Liver Disease and Transplantation (18 papers). David Semela collaborates with scholars based in Switzerland, United States and Germany. David Semela's co-authors include Jean‐François Dufour, Vijay H. Shah, Massimo Pinzani, Mercedes Fernández, Jaume Bosch, Isabelle Colle, Jordi Bruix, John P. Iredale, June Sung Lee and Ruslan Hlushchuk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

David Semela

80 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Semela Switzerland 27 1.8k 1.3k 833 562 401 85 3.1k
Young–Hwa Chung South Korea 30 1.7k 0.9× 1.7k 1.3× 745 0.9× 470 0.8× 347 0.9× 85 3.1k
Isao Okazaki Japan 25 1.2k 0.7× 939 0.7× 693 0.8× 485 0.9× 361 0.9× 102 2.5k
Yury Popov United States 37 2.3k 1.3× 2.2k 1.6× 1.5k 1.8× 1.1k 2.0× 350 0.9× 71 4.8k
Jun Itakura Japan 37 1.8k 1.0× 1.6k 1.2× 947 1.1× 745 1.3× 467 1.2× 144 4.0k
Gian Ludovico Rapaccini Italy 28 1.4k 0.8× 1.3k 1.0× 245 0.3× 593 1.1× 294 0.7× 112 2.7k
Véronique Barbu France 35 1.1k 0.6× 963 0.7× 1.5k 1.8× 1.2k 2.1× 443 1.1× 85 4.1k
Marı́a Varela Spain 24 3.4k 1.9× 2.3k 1.7× 296 0.4× 709 1.3× 410 1.0× 89 4.2k
Alessandro Granito Italy 49 2.9k 1.6× 2.6k 2.0× 411 0.5× 1.3k 2.3× 375 0.9× 149 4.8k
Atsushi Suetsugu Japan 31 924 0.5× 875 0.7× 1.1k 1.3× 307 0.5× 632 1.6× 128 3.7k
Petra Rümmele Germany 27 871 0.5× 479 0.4× 687 0.8× 1.1k 2.0× 360 0.9× 67 3.2k

Countries citing papers authored by David Semela

Since Specialization
Citations

This map shows the geographic impact of David Semela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Semela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Semela more than expected).

Fields of papers citing papers by David Semela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Semela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Semela. The network helps show where David Semela may publish in the future.

Co-authorship network of co-authors of David Semela

This figure shows the co-authorship network connecting the top 25 collaborators of David Semela. A scholar is included among the top collaborators of David Semela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Semela. David Semela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roux, Julien, Mechthild Lütge, Hung‐Wei Cheng, et al.. (2025). Circulating monocytes upregulate CD52 and sustain innate immune function in cirrhosis unless acute decompensation emerges. Journal of Hepatology. 83(1). 146–160. 6 indexed citations
2.
Ghafoor, Soleen, Felix Grimm, Fritz Ruprecht Murray, et al.. (2023). Management of biliary obstruction in patients with newly diagnosed alveolar echinococcosis: a Swiss retrospective cohort study. Swiss Medical Weekly. 153(10). 40116–40116. 4 indexed citations
3.
Gouttenoire, Jérôme, Paolo Ripellino, David Semela, et al.. (2023). Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E. Hepatology. 79(6). 1421–1431. 4 indexed citations
4.
Sawatzki, Mikael, David Semela, Yi Dong, et al.. (2023). Ultrasound Doppler technique for the diagnosis of focal nodular hyperplasia – case series and systematic review. Medical Ultrasonography. 1(1). 72–72. 4 indexed citations
5.
Ebrahimi, Fahim, David Semela, & Markus H. Heim. (2021). Impact of propofol sedation on the diagnostic accuracy of hepatic venous pressure gradient measurements in patients with cirrhosis. Hepatology International. 16(4). 817–823. 9 indexed citations
6.
Müllhaupt, Beat, Felix Brunner, Magdalena Filipowicz Sinnreich, et al.. (2021). Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue. Swiss Medical Weekly. 151(1718). w20502–w20502. 5 indexed citations
7.
Beretta‐Piccoli, Benedetta Terziroli, Guido Stirnimann, Joachim C. Mertens, et al.. (2020). Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines. Journal of Autoimmunity. 116. 102578–102578. 19 indexed citations
8.
Goossens, Nicolas, Stefano Bellentani, Andreas Cerny, et al.. (2019). Nonalcoholic fatty liver disease burden. Archive ouverte UNIGE (University of Geneva). 1 indexed citations
9.
Goossens, Nicolas, Stefano Bellentani, Andreas Cerny, et al.. (2019). Nonalcoholic fatty liver disease burden – Switzerland 2018–2030. Swiss Medical Weekly. 149(5152). w20152–w20152. 19 indexed citations
10.
Semela, David, et al.. (2018). Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept. BMJ Case Reports. 2018. bcr–2018. 5 indexed citations
11.
Müllhaupt, Beat, Philip Bruggmann, Florian Bihl, et al.. (2018). Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?. PLoS ONE. 13(12). e0209374–e0209374. 9 indexed citations
12.
Bernsmeier, Christine, Michael T. Dill, A. Provenzano, et al.. (2016). Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation. Laboratory Investigation. 96(9). 972–980. 16 indexed citations
13.
Campana, Benedetta, David Semela, Markus H. Heim, & Christine Bernsmeier. (2015). Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?. 12–18. 1 indexed citations
14.
Müllhaupt, Beat, Philip Bruggmann, Florian Bihl, et al.. (2015). Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland. PLoS ONE. 10(6). e0125214–e0125214. 22 indexed citations
15.
Morard, Isabelle, Sophie Clément, Alexandra Calmy, et al.. (2014). Clinical Significance of the CCR5delta32 Allele in Hepatitis C. PLoS ONE. 9(9). e106424–e106424. 8 indexed citations
16.
Dill, Michael T., Sonja Rothweiler, Valentin Djonov, et al.. (2012). Disruption of Notch1 Induces Vascular Remodeling, Intussusceptive Angiogenesis, and Angiosarcomas in Livers of Mice. Gastroenterology. 142(4). 967–977.e2. 98 indexed citations
17.
Chtioui, Haïthem, David Semela, M Ledermann, Arthur Zimmermann, & Jean‐François Dufour. (2007). Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. Liver International. 27(6). 764–771. 46 indexed citations
18.
Semela, David & Jean‐François Dufour. (2004). Angiogenesis and hepatocellular carcinoma. Journal of Hepatology. 41(5). 864–880. 284 indexed citations
19.
Redaelli, C., David Semela, Francine E. Carrick, et al.. (2003). Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice. Journal of Hepatology. 40(2). 305–312. 52 indexed citations
20.
Emmenegger, Urban, Andrea Reimers, Christoph A. Fux, et al.. (2001). Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. American Journal of Hematology. 68(1). 4–10. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young–Hwa Chung Breakdown of academic impact, for papers by Isao Okazaki Breakdown of academic impact, for papers by Yury Popov Breakdown of academic impact, for papers by Jun Itakura Breakdown of academic impact, for papers by Gian Ludovico Rapaccini Breakdown of academic impact, for papers by Véronique Barbu Breakdown of academic impact, for papers by Marı́a Varela Breakdown of academic impact, for papers by Alessandro Granito Breakdown of academic impact, for papers by Atsushi Suetsugu Breakdown of academic impact, for papers by Petra Rümmele
Rankless by CCL
2026